184 related articles for article (PubMed ID: 26130510)
1. Dangerous liaisons: cooperation between Pbx3, Meis1 and Hoxa9 in leukemia.
Thorne RM; Milne TA
Haematologica; 2015 Jul; 100(7):850-3. PubMed ID: 26130510
[No Abstract] [Full Text] [Related]
2. Pbx3 and Meis1 cooperate through multiple mechanisms to support Hox-induced murine leukemia.
Garcia-Cuellar MP; Steger J; Füller E; Hetzner K; Slany RK
Haematologica; 2015 Jul; 100(7):905-13. PubMed ID: 25911551
[TBL] [Abstract][Full Text] [Related]
3. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.
Li Z; Chen P; Su R; Hu C; Li Y; Elkahloun AG; Zuo Z; Gurbuxani S; Arnovitz S; Weng H; Wang Y; Li S; Huang H; Neilly MB; Wang GG; Jiang X; Liu PP; Jin J; Chen J
Cancer Res; 2016 Feb; 76(3):619-29. PubMed ID: 26747896
[TBL] [Abstract][Full Text] [Related]
4. [Identification of proteins associated with transcription factors HOXA9 and E2A-PBX1 by tandem affinity purification].
Shestakova EA; Boutin M; Bourassa S; Bonneil E; Bijl JJ
Mol Biol (Mosk); 2017; 51(3):490-501. PubMed ID: 28707666
[TBL] [Abstract][Full Text] [Related]
5. Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid Leukemia.
Mohr S; Doebele C; Comoglio F; Berg T; Beck J; Bohnenberger H; Alexe G; Corso J; Ströbel P; Wachter A; Beissbarth T; Schnütgen F; Cremer A; Haetscher N; Göllner S; Rouhi A; Palmqvist L; Rieger MA; Schroeder T; Bönig H; Müller-Tidow C; Kuchenbauer F; Schütz E; Green AR; Urlaub H; Stegmaier K; Humphries RK; Serve H; Oellerich T
Cancer Cell; 2017 Apr; 31(4):549-562.e11. PubMed ID: 28399410
[TBL] [Abstract][Full Text] [Related]
6. Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3.
Argiropoulos B; Yung E; Xiang P; Lo CY; Kuchenbauer F; Palmqvist L; Reindl C; Heuser M; Sekulovic S; Rosten P; Muranyi A; Goh SL; Featherstone M; Humphries RK
Blood; 2010 May; 115(20):4071-82. PubMed ID: 20237320
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling and candidate gene resequencing identifies pathways and mutations important for malignant transformation caused by leukemogenic fusion genes.
Novak RL; Harper DP; Caudell D; Slape C; Beachy SH; Aplan PD
Exp Hematol; 2012 Dec; 40(12):1016-27. PubMed ID: 22885519
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice.
Staffas A; Arabanian LS; Wei SY; Jansson A; Ståhlman S; Johansson P; Fogelstrand L; Cammenga J; Kuchenbauer F; Palmqvist L
Oncogene; 2017 Mar; 36(11):1516-1524. PubMed ID: 27617578
[TBL] [Abstract][Full Text] [Related]
9. MLL fusion protein-driven AML is selectively inhibited by targeted disruption of the MLL-PAFc interaction.
Muntean AG; Chen W; Jones M; Granowicz EM; Maillard I; Hess JL
Blood; 2013 Sep; 122(11):1914-22. PubMed ID: 23900238
[TBL] [Abstract][Full Text] [Related]
10. Tip60 activates Hoxa9 and Meis1 expression through acetylation of H2A.Z, promoting MLL-AF10 and MLL-ENL acute myeloid leukemia.
Yamagata K; Shino M; Aikawa Y; Fujita S; Kitabayashi I
Leukemia; 2021 Oct; 35(10):2840-2853. PubMed ID: 33967269
[TBL] [Abstract][Full Text] [Related]
11. Flt3 is dispensable to the Hoxa9/Meis1 leukemogenic cooperation.
Morgado E; Albouhair S; Lavau C
Blood; 2007 May; 109(9):4020-2. PubMed ID: 17202314
[TBL] [Abstract][Full Text] [Related]
12. Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1.
Pineault N; Abramovich C; Ohta H; Humphries RK
Mol Cell Biol; 2004 Mar; 24(5):1907-17. PubMed ID: 14966272
[TBL] [Abstract][Full Text] [Related]
13. PBX3 is essential for leukemia stem cell maintenance in MLL-rearranged leukemia.
Guo H; Chu Y; Wang L; Chen X; Chen Y; Cheng H; Zhang L; Zhou Y; Yang FC; Cheng T; Xu M; Zhang X; Zhou J; Yuan W
Int J Cancer; 2017 Jul; 141(2):324-335. PubMed ID: 28411381
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality.
Rozovskaia T; Feinstein E; Mor O; Foa R; Blechman J; Nakamura T; Croce CM; Cimino G; Canaani E
Oncogene; 2001 Feb; 20(7):874-8. PubMed ID: 11314021
[TBL] [Abstract][Full Text] [Related]
15. Frequent co-expression of HoxA9 and Meis1 genes in infant acute lymphoblastic leukaemia with MLL rearrangement.
Imamura T; Morimoto A; Takanashi M; Hibi S; Sugimoto T; Ishii E; Imashuku S
Br J Haematol; 2002 Oct; 119(1):119-21. PubMed ID: 12358913
[TBL] [Abstract][Full Text] [Related]
16. GSK-3 promotes conditional association of CREB and its coactivators with MEIS1 to facilitate HOX-mediated transcription and oncogenesis.
Wang Z; Iwasaki M; Ficara F; Lin C; Matheny C; Wong SH; Smith KS; Cleary ML
Cancer Cell; 2010 Jun; 17(6):597-608. PubMed ID: 20541704
[TBL] [Abstract][Full Text] [Related]
17. Retroviral insertional mutagenesis identifies genes that collaborate with NUP98-HOXD13 during leukemic transformation.
Slape C; Hartung H; Lin YW; Bies J; Wolff L; Aplan PD
Cancer Res; 2007 Jun; 67(11):5148-55. PubMed ID: 17545593
[TBL] [Abstract][Full Text] [Related]
18. PBX3 is an important cofactor of HOXA9 in leukemogenesis.
Li Z; Zhang Z; Li Y; Arnovitz S; Chen P; Huang H; Jiang X; Hong GM; Kunjamma RB; Ren H; He C; Wang CZ; Elkahloun AG; Valk PJ; Döhner K; Neilly MB; Bullinger L; Delwel R; Löwenberg B; Liu PP; Morgan R; Rowley JD; Yuan CS; Chen J
Blood; 2013 Feb; 121(8):1422-31. PubMed ID: 23264595
[TBL] [Abstract][Full Text] [Related]
19. NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice.
Kroon E; Thorsteinsdottir U; Mayotte N; Nakamura T; Sauvageau G
EMBO J; 2001 Feb; 20(3):350-61. PubMed ID: 11157742
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of the HOXA9/MEIS1 axis in acute leukemia.
Collins CT; Hess JL
Curr Opin Hematol; 2016 Jul; 23(4):354-61. PubMed ID: 27258906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]